These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1635218)

  • 1. [Etiological and physiopathological significance of taurine in hypertension].
    Ando K; Fujita T
    Nihon Rinsho; 1992 Apr; 50 Suppl():374-81. PubMed ID: 1635218
    [No Abstract]   [Full Text] [Related]  

  • 2. The antihypertensive effect of taurine in DOCA-salt rats.
    Fujita T; Sato Y
    J Hypertens Suppl; 1984 Dec; 2(3):S563-5. PubMed ID: 6152784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of stress, salt, and blood pressure.
    Anderson DE
    Annu Rev Physiol; 1984; 46():143-53. PubMed ID: 6370103
    [No Abstract]   [Full Text] [Related]  

  • 4. [Autonomic nervous system in essential hypertension].
    Kuchii M
    Nihon Rinsho; 1992 Apr; 50 Suppl():257-65. PubMed ID: 1635201
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of nifedipine coat-core and amlodipine on systemic arterial stiffness modulated by sympathetic and parasympathetic activity in hypertensive patients.
    Fukuda M; Masuda T; Ogura MN; Moriya T; Tanaka K; Yamamoto K; Ishii A; Yonezawa R; Noda C; Izumi T
    Hypertens Res; 2009 May; 32(5):392-8. PubMed ID: 19373239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taurine attenuates hypertension and improves insulin sensitivity in the fructose-fed rat, an animal model of insulin resistance.
    Anuradha CV; Balakrishnan SD
    Can J Physiol Pharmacol; 1999 Oct; 77(10):749-54. PubMed ID: 10588478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hypertension with oral taurine: experimental and clinical studies.
    Militante JD; Lombardini JB
    Amino Acids; 2002; 23(4):381-93. PubMed ID: 12436205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypotensive effect of taurine. Possible involvement of the sympathetic nervous system and endogenous opiates.
    Fujita T; Sato Y
    J Clin Invest; 1988 Sep; 82(3):993-7. PubMed ID: 2971083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sympathetic activity in essential hypertension.
    Koch-Weser J
    N Engl J Med; 1973 Mar; 288(12):627-9. PubMed ID: 4405674
    [No Abstract]   [Full Text] [Related]  

  • 10. Cilnidipine inhibits the sympathetic nerve activity and improves baroreflex sensitivity in patients with hypertension.
    Kishi T; Hirooka Y; Konno S; Sunagawa K
    Clin Exp Hypertens; 2009 May; 31(3):241-9. PubMed ID: 19387900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral taurine supplementation prevents fructose-induced hypertension in rats.
    Harada H; Tsujino T; Watari Y; Nonaka H; Emoto N; Yokoyama M
    Heart Vessels; 2004 May; 19(3):132-6. PubMed ID: 15168061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of the sympathetic nervous system in the pathogenesis of arterial hypertension in rats with genetically conditioned hypertension].
    Przybylski J; Januszewicz P
    Acta Physiol Pol; 1978; 29 Suppl 17():21-31. PubMed ID: 751460
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hypertension and the sympathetic nervous system - recent developments in research and treatment].
    Grisk O
    Dtsch Med Wochenschr; 2009 Nov; 134(45):2289-93. PubMed ID: 19876804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sympathetic nervous factors, pressure variability and organ damage in arterial hypertension].
    Mancia G; Seravalle G; Grassi G
    Ann Ital Med Int; 1997; 12(4):217-22. PubMed ID: 9773576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of impaired parasympathetic control of the heart in hypertension: evidence against reduced cardiac vagal responsiveness.
    Ferrari AU; Daffonchio A; Zeeuwe P; Franzelli C; Gerosa S; Mancia G
    J Hypertens Suppl; 1991 Dec; 9(6):S94-5. PubMed ID: 1819026
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of doxazosin on ambulatory blood pressure and sympathetic nervous activity in hypertensive Type 2 diabetic patients with overt nephropathy.
    Yasuda G; Hasegawa K; Kuji T; Ogawa N; Shimura G; Umemura S; Tochikubo O
    Diabet Med; 2005 Oct; 22(10):1394-400. PubMed ID: 16176202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sympathetic nervous system in primary hypertension.
    Weber MA; Drayer JI
    Miner Electrolyte Metab; 1982 Feb; 7(2):57-66. PubMed ID: 6763142
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin converting enzyme inhibition, parasympathetic activity and exercise in essential hypertension.
    Fariello R; Alicandri C; Boni E; Zaninelli A; Cantalamessa A; Corda L; Muiesan G
    Drugs Exp Clin Res; 1989; 15(11-12):571-6. PubMed ID: 2561594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurogenically maintained component in hypertension.
    Smirk FH
    Circ Res; 1970 Oct; 27():Suppl 2:55-63. PubMed ID: 5506149
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of the sympathetic system in the maintenance of human hypertension.
    de Champlain J; Cousineau D; Lapointe L
    Clin Invest Med; 1978; 1(3-4):123-8. PubMed ID: 42501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.